296/300 words): 1 Teriparatide (PTH 1-34 ) promotes skeletal repair and increases bone mass. Vitamin K is implicated 2 in bone mineralization as a coenzyme of -carboxylase for the Gla proteins, and therefore vitamin 3 K insufficiency caused by malnutrition or therapeutic intake of the vitamin K antagonist warfarin 4 could affect the efficacy of PTH 1-34 therapy for bone repair. In the present study, we investigated 5 whether vitamin K influences the efficacy of PTH 1-34 therapy for bone repair in a rat osteotomy 6 model. Female 12-week-old Sprague-Dawley rats were subjected to a closed midshaft osteotomy 7 of the femur and randomized into four groups (n=10 per group): Vehicle, PTH 1-34 (daily 30 8 μg/kg/day subcutaneous injection) + solvent (orally, three times a week), PTH 1-34 + warfarin (0.4 9 mg/kg/day orally, three times a week), and PTH 1-34 + vitamin K 2 (menatetrenone, 30 mg/kg/day 10 orally, three times a week). Serum -carboxylated and uncarboxylated osteocalcin (Gla-OC and 11
Introduction 1
Materials and methods 1 Animals and osteotomy model 2 All animal studies were performed in accordance with protocols approved by the Hokkaido 3 University's Committee on Animal Resources. Female Sprague-Dawley rats (n = 40; 10 weeks of 4 age; CLEA Japan, Inc., Tokyo, Japan) were maintained at 20°C on a 12-h light/12-h dark cycle 5 with free access to water and rat food containing 0.98% Ca, 0.80% Pi, and 15.4 mg/kg vitamin K 3 6 (Labo MR Stock; Nosan Corporation Life-Tech Department, Yokohama, Japan). Following a 7 2-week adaptation period to the new environment, all rats were stratified according to bodyweight 8 and underwent a unilateral osteotomy of the femur. Briefly, transverse osteotomy at the mid-shaft 9 femur was performed using a threaded wire saw (MDS36-30 T-saw, MANI, Tochigi, Japan), 10 which was inserted percutaneously, and then the osteotomized femur was stabilized with an 11 intramedullary titanium wire (Ø= 1.0 mm; Synthes, Tokyo, Japan). This closed osteotomy 12 procedure does not preserve periosteum but minimizes other soft tissue damage compared to 13 conventional open osteotomy. This model was modified for the femur from a previous report [17] . 14 15
Experimental design 16
After osteotomy, all rats were randomized into four groups within each stratum according to 17 the following treatment schedule: vehicle control group (n = 10), PTH 1-34 group (n = 10), PTH 1-34 18 + warfarin group (n = 10), and PTH 1-34 + vitamin K 2 group (n = 10). Recombinant human PTH 1-34 19 (Forteo®; Eli Lilly, Ltd., Kobe, Japan) at a dosage of 30 μg/kg/day or phosphate-buffered saline 20 was administered to the animals by daily subcutaneous injections [15, 18] . Vitamin K 2 21 (menatetrenone; Eisai Co., Ltd., Tokyo, Japan) was suspended in fatty acid (Miglyol 812; Mitsuba 22 Trading, Co., Ltd, Tokyo, Japan) at a dose of 30 mg/ml/kg bodyweight and administered by gavage 1 three times a week [16, 19, 20] . To cancel the effect of dietary vitamin K, warfarin was suspended 2 in distilled water at a dose of 0.4 mg/ml/kg body weight and administered by gavage three times a 3
week [21] . Every two weeks after the surgery, bodyweight was monitored, tail vein blood was 4 collected, and micro-computed tomography (micro-CT) of the femur was performed under inhaled 5 sedation with isoflurane (Forene®). At 8 weeks after the osteotomy, the animals were killed and 6 the treated femora were collected. Micro-CT was performed for all femora. Half of the 10 femora 7 were subjected to biomechanical testing and the other half were subjected to histologic 8 examination. 9
Serum Gla-OC and Glu-OC levels 10
Sandwich enzyme-linked immunosorbent assays were performed using commercially 11 available kits to determine the serum Gla-OC and Glu-OC levels (Takara Bio Inc., Shiga, Japan). 12
All samples were assayed in duplicate. A standard curve was generated for each protein, and the 13 absolute concentrations were determined from the standard curve. 14
Biomechanical testing 15
A three-point bending breakdown test was performed at the fracture site of the femora using a 16 load mechanical universal testing machine (Model 3365, Instron Corp., Norwood, MA, USA). The 17 femur was placed with its anterior surface facing upward on the two lower support bars 15 mm 18 apart, and the loading bar was positioned at the fracture site (anteroposterior position). The load 19 was applied at a rate of 0.2 mm/min until breakage. The ultimate load (N) and stiffness (N/mm) 20
were calculated from the load-deformation curve. As previously described, the load-displacement 21 data were normalized to obtain intrinsic material properties such as ultimate stress and elastic 22 modulus, which are independent of cross-sectional size and shape [5] . 1
Micro-CT analysis. 2 Femora were scanned individually by micro-CT (CT, R_mCT2; Rigaku, Tokyo, Japan) at a 3 20-µm isotropic resolution. Three-dimensional reconstruction of mineralized tissue and 4 quantitative analysis of fracture calluses were performed using TRI-BONE software (Ratoc 5 System Engineering, Tokyo, Japan) in accordance with the guidelines described in Bouxsein et al 6 [22] . The region of interest was set at the osteotomy site including the region 2.5 mm extending 7 proximally and distally to the center of the gap with a total of 250 CT axial scans. The total bone 8 volume (BV total ) was quantified first and then original bone volume (BV original ) was calculated by 9 manually segmenting the original bone from the surrounding mineralized callus. The difference 10 between BV total and BV original was computed to determine the mineralized callus volume (BV callus ). 11
The threshold for segmentation of the mineralized callus was 200 mg of hydroxyapatite/cm 3 , 12 based on a phantom comprising known hydroxyapatite concentrations [23] . Bone mineral content 13 of callus (BMC callus ) was measured and tissue mineral density of mineralized callus (mBMD callus = 14 Japan) was injected subcutaneously at 7 days and 2 days, respectively, before the rat was killed. 18
The femora were fixed in 70% ethanol, and stained with Villanueva Bone Stain. These specimens 19
were then subjected to undecalcified tissue processing. The specimens were embedded in 20 methyl-methacrylate (Wako Chemicals, Kanagawa, Japan) and sectioned at 5 μm in the sagittal 21 plane. The osteotomy site of the femur was examined by fluorescence microscopy (BX53, Olympus, Tokyo, Japan) to evaluate the dynamic parameters of bone formation. allow for adequate healing for the three-point bending test. Consistent with previous reports, 1 PTH 1-34 administration increased the ultimate stress and stiffness of the osteotomized femur to 2.4 2 and 1.7 times those in the vehicle group [18, 26] . Concomitant use of warfarin attenuated the effect 3 of PTH 1-34 administration on the biomechanical properties (ultimate stress and stiffness to 0.5 and 4 0.6 times those in the PTH 1-34 group). Meanwhile, concurrent use of vitamin K 2 and PTH 1-34 5 showed some additive, albeit statistically insignificant, effects on the biomechanical properties 6 (ultimate stress and stiffness to 1.5 and 1.3 times those in the PTH 1-34 group). The effects of 7 warfarin and vitamin K 2 on intrinsic material properties of the osteotomized femur in 8 PTH 1-34 -treated rats, including elastic modulus and bending strength, were similar to those on 9 ultimate stress and stiffness (Table 1) . Although we failed to detect a statistically significant 10 difference among the PTH 1-34 administration groups, we found a statistically significant 11 correlation between Gla-OC levels at 2, 4, and 6 weeks after surgery and the mechanical properties 12 (Table 2) . 13
Effect of vitamin K insufficiency or supplementation on the efficacy of PTH 1-34 therapy in 14 radiographic parameters of bone repair 15
To assess the bone repair process after osteotomy, longitudinal micro-CT analysis was 16 performed at 2, 4, 6, and 8 weeks after osteotomy. The effect of PTH 1-34 on bone repair was 17 apparent on micro-CT reconstruction images by the large and solid callus formation ( Fig. 2A) [5, 18 15, 27] . The gap at the osteotomy site was filled with calcified bone within 6 weeks after 19 osteotomy in PTH 1-34 and PTH 1-34 + vitamin K 2 groups, whereas mineralization of the osteotomy 20 gap tended to be delayed in PTH 1-34 + warfarin group. 21
To more carefully assess the effect of PTH 1-34 and vitamin K level on radiographic healing, 22 quantitative analysis of the calcified callus was performed after removal of the intramedullary 23 metal pin 8 weeks after osteotomy. BV callus and mBMD callus were higher in the PTH 1-34 1 administration groups than in the vehicle groups (Fig. 2B, C) . Although PTH 1-34 + warfarin group 2 tended to show lower BV callus and mBMD callus than the other two PTH 1-34 groups, we failed to 3 detect a significant difference in BV callus and mBMD callus among the PTH 1-34 administration 4 groups. 5
Effect of vitamin K insufficiency or supplementation for the efficacy of PTH 1-34 therapy on 6 histologic parameters of bone repair 7
To better understand the mechanism responsible for the drug effects on biomechanical 8
properties, we analyzed the histology at 8 weeks after surgery. Similar to the findings of the 9 micro-CT study, the calluses were densely formed ( Fig. 3A-D) and BV/TV was greater in the 10 PTH 1-34 administered groups than in the vehicle group (Fig. 3M) . The osteoid, which is 11 unmineralized bone matrix stained red-purple with Villanueva staining, was abundant in the 12 specimens of the PTH 1-34 + warfarin group (Fig. 3G and K) , and the OV/BV was higher in the 13 PTH 1-34 + warfarin group compared to the vehicle and PTH 1-34 + vitamin K groups (Fig. 3N) . 14 N.Ob/BS, Ob.S/BS, and MS/BS were greater in the PTH 1-34 administered groups than in the 15 vehicle group but these are similar among PTH 1-34 , PTH 1-34 + warfarin, and PTH 1-34 + vitamin K 2 16 groups ( Fig. 3O and P) . Analysis of the BFR revealed that PTH 1-34 enhanced the mineralization of 17 the fracture callus based on an increase in MAR and BFR/BS (Fig. 3I-L The present study addressed whether vitamin K levels affect the efficacy of PTH 1-34 therapy for 23 bone repair. Although we could not provide direct evidence for the correlation between vitamin K 1 levels and the efficacy of PTH 1-34 therapy for bone repair, our data suggest that impaired therapy, we selected a promising dose, 30 g/kg, for anabolic effects on rat bone repair. However, 1 the effect of combination therapy of lower dose PTH 1-34 and vitamin K on bone healing should be 2 examined in the future study. If vitamin K could minimize the required dosage of PTH 1-34 to 3 enhance bone healing, the combination therapy would be helpful for clinical translation of PTH 1-34 4 therapy for bone repair by overcoming the problems associated with high dose PTH 1-34 therapy 5 such as high cost, incidence of hypercacemia and osteosarcoma. 6
There are several limitations to this study. First, we measured OC levels but did not measure 7 serum vitamin K levels because of technical difficulties in precisely measuring vitamin K levels 8 from the small amounts of serum collected. Because animals had free access to food containing 9 vitamin K 3 , the vitamin K levels might have differed among rats. This might be why we detected a 10 correlation between postoperative Gla-OC levels and mechanical properties, but failed to detect a 11 significant difference in the mechanical properties among the PTH 1-34 , PTH 1-34 + warfarin, and 12 PTH 1-34 + vitamin K groups. Second, the number of rats studied (n = 5 per group for biomechanical 13 testing) may be insufficient to detect "small" effects of vitamin K 2 on the mechanical properties of 14 the osteotomized femur. However, the power analysis suggests that n=34 rats per groups would be 15 necessary to detect significant difference in bending strength and such larger studies would not 16 alter the major conclusions in this study. Third, we did not evaluate the effect of other Gla-proteins, 17 such as Matrix Gla protein (MGP) on bone repair. MGP is another major Gla-protein in bone and 18 cartilage. While the function of MGP is not yet fully understood, it is thought to regulate the 19 development of cartilage and to inhibit mineralization. Therefore, the involvement of MGP in 20 bone repair requires further investigation. 21
In summary, we demonstrated that PTH 1-34 therapy cannot fully exert its effect on bone repair 22 under conditions of vitamin K insufficiency in rats. This finding suggests that PTH 1-34 therapy is 23 less effective for enhancing bone repair in patients with a low dietary vitamin K intake or patients 1 using the vitamin K antagonist warfarin as an anticoagulant therapy. Conversely, concomitant use 2 of vitamin K 2 with PTH 1-34 should improve mechanical recovery of fractured bone by regulating 3 the growth and maturation of hydroxyapatite crystal especially in patients with a low dietary 4 vitamin K intake. 5 6 Disclosure 7
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